-The Times of India MUMBAI: After Parliament's assent to the Lokpal Bill, India Inc has engaged legal eagles and consultants to examine its ramifications. At first glance, it appears that nothing much changes for the corporate sector, which is governed by anti-corruption legislations such as the Indian Penal Code or The Prevention of Corruption Act. Besides, as business is now global, anti-corruption laws of other countries also apply. Yet, with the bill...
More »SEARCH RESULT
Total Matching Records found : 501
Pills for polls-Kundan Pandey
-Down to Earth The free medicine scheme in Rajasthan may benefit Congress Of the many poll sops that Rajasthan Chief Minister Ashok Gehlot doled out in the past two years, the one scheme that seems to have struck the right chord with voters is the initiative to give free essential medicines at government healthcare facilities. The Mukhyamantri Nishulk Dava Yojna, launched in 2011, has offered some hope to the incumbent Congress government,...
More »80% of medicines not covered by price control order -Rema Nagarajan
-The Times of India About 38 million people in India (which is more than Canada's population) fall below the poverty line every year due to healthcare expenses, of which 70% is on purchase of drugs. Yet, the much-awaited drug price control order (DPCO) 2013, meant to control the price of medicines does not cover over 80% of the medicines in the market. Many drugs crucial for India's disease profile have been...
More »Drug price control covers too little, riddled with loopholes -GS Mudur
-The Telegraph New Delhi: The price caps imposed by the Indian government on 348 drugs earlier this year have created only an illusion of control, keeping many medicines for conditions ranging from asthma to diabetes and heart disease beyond price regulations, experts said today. The price control order issued by the department of pharmaceuticals in May has led to a 22 per cent reduction in the average cost of some 250 medicines,...
More »Indian biotech aiming to be $100 billion sector by 2025: Shaw
-PTI NEEMRANA (RAJASTHAN): Indian biotechnology sector is looking to be a $100 billion sector by 2025, Biocon chief Kiran Mazumdar-Shaw said here on Saturday. "We want to make Indian biotechnology a $100 billion sector by 2025. I really believe this can be done if we have right policies in place, right resources and right investments," Biocon chairman and managing director Kiran Mazumdar-Shaw told PTI. She was speaking on the sidelines of the third...
More »
